Usefulness of serum neopterin levels in acute decompensated heart failure to predict renal dysfunction

References

• Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, Burger AJ, Elkayam U. (2004). Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 94:957–960.
   PubMed Web of Science ®Google Scholar
• Apostolakis S, Lip GY, Shantsila E. (2010). Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res 85:649–660.
   PubMed Web of Science ®Google Scholar
• Belziti CA, Bagnati R, Ledesma P, Vulcano N, Fernández S. (2010). Worsening renal function in patients admitted with acute decompensated heart failure: incidence, risk factors and prognostic implications. Rev Esp Cardiol 63:294–302.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B; POSH Investigators. (2006). Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216–1222.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M. (2006). Usefulness of neopterin levels and left ventricular function for risk assessment in survivors of acute myocardial infarction. Int J Cardiol 111:318–320.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC. (2009). Inflammatory systemic biomarkers in setting acute coronary syndromes–effects of the diurnal variation. Curr Drug Targets 10:1001–1008.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Laynez-Cerdeña I, Kaski JC. (2010). Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Atherosclerosis 211:574–578.
   PubMed Web of Science ®Google Scholar
• Estévez-Loureiro R, Recio-Mayoral A, Sieira-Rodríguez-Moret JA, Trallero-Araguás E, Kaski JC. (2009). Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis 207:514–518.
   PubMed Web of Science ®Google Scholar
• Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. (2004). Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra-Sanchez L, Kaski JC. (2009). The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 16:4644–4653.
   PubMed Web of Science ®Google Scholar
• García-González MJ, Domínguez-Rodríguez A, Abreu-González P. (2008). Light-dark variations in neopterin serum levels in patients with ST-segment elevation acute coronary syndrome undergoing primary angioplasty. Rev Esp Cardiol 61:1280–1286.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L; International Working Group on Acute Heart Failure Syndromes. (2005). Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968.
   PubMed Web of Science ®Google Scholar
• Godai K, Uemasu J, Kawasaki H. (1991). Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 36:141–146.
   PubMed Web of Science ®Google Scholar
• Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O’connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. (2002). The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8:136–141.
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Wirleitner B, Fuchs D. (2003). Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 52:313–321.
   PubMed Web of Science ®Google Scholar
• Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. (1984). Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316.
   PubMed Web of Science ®Google Scholar
• Lassus JP, Harjola VP, Peuhkurinen K, Sund R, Mebazaa A, Siirilä-Waris K, Miettinen K, Punnonen KR, Melin J, Pulkki K, Nieminen MS; FINN-AKVA study group. (2011). Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome. Biomarkers 16:302–310.
   PubMed Web of Science ®Google Scholar
• Lhee HY, Kim H, Joo KJ, Jung SS, Lee KB. (2006). The clinical significance of serum and urinary neopterin levels in several renal diseases. J Korean Med Sci 21:678–682.
   PubMed Web of Science ®Google Scholar
• McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. (2004). Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109:1004–1009.
   PubMed Web of Science ®Google Scholar
• Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. (2008). Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10:188–195.
   PubMed Web of Science ®Google Scholar
• Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E. (2011). Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 32:1390–1397.
   PubMed Web of Science ®Google Scholar
• Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, López-Sendón J, Mebazaa A, Metra M, Rhodes A, Swedberg K; Grupo de Trabajo sobre la Insuficiencia Cardíaca Aguda de la Sociedad Europea de Cardiología; la Sociedad Europea de Medicina Intensiva (ESICM). (2005). [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. Rev Esp Cardiol 58:389–429.
   PubMed Web of Science ®Google Scholar
• Oda K, Arai T, Nagase M. (1999). Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction. Am J Kidney Dis 34:611–617.
   PubMed Web of Science ®Google Scholar
• O’M Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470.
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. (2003). Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41:1212–1218.
   PubMed Web of Science ®Google Scholar
• Smilde TD, Hillege HL, Voors AA, Dunselman PH, Van Veldhuisen DJ. (2004). Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 94:240–243.
   PubMed Web of Science ®Google Scholar
• Trachtenberg BH, Hare JM. (2009). Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5:561–577.
   PubMedGoogle Scholar
• Urbschat A, Obermüller N, Haferkamp A. (2011). Biomarkers of kidney injury. Biomarkers 16 Suppl 1:S22–S30.
   PubMed Web of Science ®Google Scholar